Gene Expression Changings After Bariatric Surgery in Morbid Obese Patients and Type 2 Diabetes Remission

Obes Surg. 2019 Feb;29(2):649-650. doi: 10.1007/s11695-018-03648-9.

Authors

Taiebeh Mohammadi Farsani^{1

2}, Gholamreza Mohammadi Farsani^{1

3}, Ali Kabir⁴

Affiliations

¹ Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
² Department of Medical Biotechnology , Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran.
³ Department of Clinical Nutrition, School of Nutrition and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. kabir.a@iums.ac.ir.

PMID: 30565099
DOI: 10.1007/s11695-018-03648-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Bariatric Surgery*
Diabetes Mellitus, Type 2*
Female
Gastric Bypass*
Ghrelin
Humans
Obesity, Morbid / surgery*
Stomach
Up-Regulation

Substances

Ghrelin